In the lengthy and complex clinical trial process, patients are partners in the development of new, innovative medicines. Biopharmaceutical companies are working with partners to increase awareness and encourage greater participation and representation in these trials to continue developing lifesaving treatments and cures.
LATEST ARTICLES
-
Clinical Trials: The Key to Innovative New Medicines
Learn more about the importance of clinical trials to the biopharmaceutical innovation process.
-
Florida Clinical Trials
Recently, America's biopharmaceutical companies joined the American Cancer Society for the Cancer Action Network Clinical Trials Policy Forum at the Mayo Clinic in Jacksonville, Florida.
-
Recognizing Diversity in Clinical Trials
Every time you take a medicine – even if it's just for a headache – you are benefitting from the results of a clinical trial.
RELATED ARTICLES
By the Numbers: Vaccines and Treatments in Development for COVID-19
America's biopharmaceutical companies are committed to developing solutions to help diagnose, treat and prevent COVID-19.
Speeding Innovation with AI and Big Data
Biopharmaceutical researchers are using AI to cut the time and costs it takes to manually sift through datasets.
Why Has Research into Alzheimer's Disease Been So Hard?
Why, when we have seen such progress in our ability to treat other diseases, such as cancer, diabetes and HIV, has progress in Alzheimer's research been so difficult to achieve?
Researcher Profile: Kelly Knee
As a principal scientist working on sickle cell disease in the Rare Disease Research Unit (RDRU) at Pfizer, Kelly Knee is a jack of all trades.
Patient Resources
America's Biopharmaceutical Companies are researching and developing thousands of new treatments and cures, and helping more patients every day.
How Can Biomarkers and Surrogate Endpoints Enhance R&D of Medicines?
In the age of personalized medicine, biomarkers are emerging as important tools in drug development.
Clinical Trial Provides Patient A Second Chance
Twenty years ago, there were no effective treatments for the disease from which Marina Symcox was suffering. Learn more about the role clinical trials played in giving Marina a second chance.
